Bausch Health (BHC.US), a pharmaceutical and medical device company, rose more than 5% during today’s session. Stock soared as an activist billionaire investor, Carl Icahn, has taken a stake in the company. Icahn disclosed a 7.8% stake in a regulatory filing. An activist investor has a reputation for pushing for major changes in companies. He said earlier that he believed that Bausch Health stock is undervalued and planned to discuss ways to enhance shareholder value with management and board. The investment makes him the company’s largest single shareholder.
Bausch Health (BHC.US) share price has reached 2019-highs, just a notch below $32 level. Stock has surged in recent weeks and broke above key long-term price zone around $27.50. Source: xStation5
MicroStrategy in trouble? Shares down 67% from the highs ✂
Stock of the Week – NVIDIA (21.11.2025)
UK Budget preview
DE40: European tech and defence stocks sell-off
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
